Reuters logo
BRIEF-Insys therapeutics accepts resignation of Santosh Vetticaden, interim CEO
2017年4月17日 / 上午10点22分 / 5 个月前

BRIEF-Insys therapeutics accepts resignation of Santosh Vetticaden, interim CEO

April 17 (Reuters) - Insys Therapeutics Inc

* On April 11, 2017, Insys Therapeutics accepted resignation of Santosh Vetticaden, interim chief executive officer Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below